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Introduction
In Fabry disease, an X-linked lysosomal storage disor-
der, deficient activity of the enzyme α-galactosidase A
(α-Gal A) [6, 22] leads to intracellular accumulation of
globotriaosylceramide predominantly in the vascular
tissue, eye, skin, kidney, heart, and nervous system [7,
10]. Disease prevalence is estimated between 1:40,000
and 1:117,000 live births [27]. If later-onset variant phe-
notypes are included, incidence ranges from 1:3100 to
1:4600 [39]. The clinical onset in childhood is character-
ized by painful acroparaesthesias, hypohydrosis, typical
angiokeratoma, gastrointestinal symptoms, such as ab-
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■ Abstract Progressive hearing
(pHL) and vestibular (pVL) loss
are frequent deficits in Fabry dis-
ease (FD). Recently, enzyme re-
placement therapy (ERT) with hu-
man α-galactosidase A has become
available. Here, we investigate the
association between pHL and pVL
in FD and their ERT responses.
Pure tone audiometry (PTA) and
head impulse testing (HIT) were
administered at baseline in 47 pa-
tients (25 male, 18–60 y; 22 female,
17–74 y), of whom 24 also received
caloric irrigation (CI). Of the 47
patients, 38 (24 male) were tested
both before and during ERT (fol-
low-up ≤ 60 months). ERT con-
sisted of agalsidase alfa infusions.
At baseline, pHL was present in
88 % of males and 86 % of females.
Over all tested frequencies (range:
0.5–6 kHz), pHL was significantly
(two-way ANOVA: p < 0.05) greater
at higher age and in males, with
largest deficits at high frequencies.
When assessed with HIT, 80 % of
males and 77 % of females had
pVL. pVL was significantly greater
at higher age and in males. Tested
with CI, 21 % of males and 0 % of
females had pVL. No associations
among individual semicircular
canal (SCC) deficits, as tested by
HIT, and hearing was observed in
individual ears. After ≥ 18 months
of ERT, pVL was significantly
smaller than at baseline (ANOVA
for HIT: p < 0.01). In contrast, pHL
remained unchanged by ERT over
60 months (p > 0.05). We conclude
that pHL and pVL prevalences are
similar in FD. To detect pVL, HIT is
more sensitive than CI. We specu-
late that pHL and pVL emerge
from lesions within the vestibulo-
cochlear labyrinth, because no spe-
cific patterns of vestibulo-cochlear
deficits were observed, as expected
if lesions were more proximal
along the inferior or superior
branch of the vestibulo-cochlear
nerve or labyrinthine artery. Fi-
nally, ERT stabilizes auditory and
even improves vestibular function.
■ Key words lysosomal disease ·
Fabry disease · head impulse test ·
caloric irrigation · pure tone
audiogram
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dominal pain and diarrhea, and corneal dystrophy [7,
10, 26]. Renal failure, cardiomyopathy, and cerebrovas-
cular disease cause premature death, on average about
two decades earlier than in the general population
[24–26]. Although inheritance is X-chromosomal
linked, females can be affected to a mild or severe degree
due to random X-chromosomal inactivation [42]. Re-
cently enzyme replacement therapy (ERT) with recom-
binant or gene-activated human α-Gal A provided evi-
dence of reversibility of several clinical manifestations,
notably of cardiac, renal, and peripheral neuropathic
symptoms [5, 11, 19, 36, 40, 43].
Hearing loss has often been linked with Fabry dis-
ease, but only recent studies have ascertained its high
prevalence [9, 18, 26]. Predominantly, hearing loss in
Fabry disease is of sensorineural type [14, 15, 18, 34].
Likewise, vestibular function seems to be commonly af-
fected in Fabry disease, but so far only small case series
are available [9, 29, 32]. When cochlear and vestibular
impairments in patients with Fabry disease are com-
pared, hearing loss is more frequently reported than
vestibular loss and an independent involvement be-
tween the cochlea and the vestibular labyrinth has been
suggested [9, 29]. While studies agree on the prevalence
of hearing loss, the prevalence of vestibular impairment
varies considerably, i. e. ranges from 30 % [9] to 50 %
[29] when tested with caloric irrigation, and up to 70 %
when tested with search-coil head impulses [32].
Caloric irrigation and the search-coil head impulse
test are both validated assessments of peripheral
vestibular function. The advantage of the search-coil
head impulse test over caloric irrigation consists in a
more physiological stimulation of the high-frequency
range of the vestibular system and the possibility to de-
termine the function of individual semicircular canals
[3, 4, 37].
The present study was prospectively conducted in
Fabry patients with the following goals: 1) to determine
the prevalence of auditory and vestibular impairments
in male and female patients; 2) to compare vestibular re-
sponses as tested by head impulses and caloric irriga-
tion; 3) to correlate vestibular function to hearing; 4) to
determine the effect of ERT on vestibular and auditory
function.
Subjects and methods
■ Subjects
Forty-seven patients (25 male, 18–60 y, mean 40 y; 22 female, 17–74 y,
mean 34 y) diagnosed with Fabry disease (FD) were vestibularly and
audiologically tested at baseline examination. The diagnosis of FD
was confirmed in all patients by enzyme assay or DNA analysis. Pa-
tients were consecutively recruited starting February 2001.Vestibular
assessments at baseline included head impulse testing in all 47 pa-
tients, of whom 24 patients (16 male, 18–60 y, mean 41 y; 8 female,
17–74 y, mean 44) also received caloric irrigation. Enzyme replace-
ment therapy (ERT) was given to 38 (24 male) of the 47 patients. All
FD patients receiving ERT were tested at relatively regular intervals
during a period of up to 60 months. ERT consisted of intravenous in-
fusions of gene-activated or recombinant human α-galactosidase A.
Agalsidase alfa (Replagal®; TKT Europe – SS, Danderyd, Sweden) was
given at a dose of 0.2 mg/kg every two weeks. The comparison group
for vestibular head impulse testing comprised 28 healthy subjects (13
male; aged 18–75 y, mean 44), while normal values for audiometric
testing were taken from ISO 70291, an internationally accepted age-
and gender-matched control data set. Informed consent was obtained
from patients and healthy human subjects after a full explanation of
the experimental procedure. The protocol was approved by a local
ethics committee and was in accordance with the ethical standards
laid down in the 1964 Declaration of Helsinki for research involving
human subjects.
■ Auditory testing
Routine pure tone audiometry was performed for auditory assess-
ment. The audiometric type, amount, and configuration of hearing
loss were further analyzed. The type of hearing loss was classified as
sensorineural (average air-bone gap of less than 15 dB for 0.5, 1 and 2
kHz), conductive (normal bone conduction thresholds and average
air-bone gap of 15 dB or more for 0.5, 1, and 2 kHz), or mixed (bone
conduction threshold greater than 20 dB HL in combination with av-
eraged air-bone gap 15 dB or more for 0.5, 1, and 2 kHz) according to
the European Working Group on Genetics and Hearing Impairment.2
Hearing loss was categorized according to pure-tone air conduction
thresholds at 0.5, 1, 2, 4, and 6 kHz relative to 90th percentiles of the
age- and gender-matched ISO 7029 control data. To determine the
shape of audiometric configurations, we computed the following
thresholds (T) for each of the two ears in every patient:
low frequency threshold: T(low) = [T(0.5 kHz) + T(1 kHz)]/2
mid frequency threshold: T(mid) = T(2 kHz)
high frequency threshold: T(high) = [T(4 kHz) + T(6 kHz)]/2
Using these three thresholds, audiometric configurations were de-
fined as follows (modified definitions from European Working Group
on Genetics and Hearing Impairment2 and [9]):
 flat: |T(low) – T(mid)| ≤ 15 dB HL AND |T(mid) – T(high)| ≤ 15
dB HL
 mid frequency U-shaped: |T(mid) – T(low)| > 15 dB HL AND
|T(mid) – T(high)| > 15 dB HL
 high frequency: |T(high) – T(low)| > 15 dB HL AND
|T(mid) – T(low)| < [T(high) – T(low)]/3
 sloping: |T(high) – T(low)| > 15 dB HL AND |T(mid) – T(low)| >
[T(high) – T(low)]/3
 low frequency: |T(low) – T(high)| > 15 dB HL AND
|T(mid) – T(high)| < [T(low) – T(high)]/3
 rising: |T(low) – T(high)| > 15 dB HL AND |T(mid) – T(high)| >
[T(low) – T(high)]/3
1 International Organization for Standardization (2000). Acoustics –
Statistical distribution of hearing thresholds as a function of age, ISO
7029:2000
2 http://www.gendeaf.org. Recommendations for description of ge-
netic and audiological data for families with nonsyndromic heredi-
tary hearing impairment; Composed by the GENDEAF study group
on genotype phenotype associations
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■ Vestibular testing
Caloric irrigation was performed according to the Fitzgerald-
Hallpike testing protocol [13]. In sequence, unilateral 30 °C-cold and
44 °C-warm water irrigations during 20 s with 20 mL of water were
performed on either side and eye movement responses were video-
oculographically recorded for 180 s [37]. The asymmetry of periph-
eral vestibular function in percent, i. e. the canal paresis factor,was de-
termined by Jongkees formula [21]. For quantitative head impulse
testing, three-dimensional eye and head movements were measured
in a magnetic frame (Remmel type system,modified by A.Lasker,Bal-
timore, MA, USA) using dual search-coils. Search-coils were cali-
brated before each session [41]. After anesthetizing the conjunctiva
with oxybuprocaine 0.4 %, one search-coil was placed on the right eye
around the cornea and the other was tightly fixed on the forehead
with adhesive tape.Voltages were sampled at 16 bits at a frequency of
1000 Hz and stored on the hard disk of a computer. During experi-
ments, subjects were seated inside the magnetic coil frame (side
length: 1.4 m). Care was taken to position the center of the inter-
pupillary line in the center of the magnetic frame. Rotational head
thrusts (amplitude: 20–40°; duration: 150–200 ms; peak velocity: ~
300 °/s; peak acceleration: ~ 10000 °/s2) were applied approximately
along the planes of the horizontal, left anterior and right posterior
(LARP), and right anterior and left posterior (RALP) semicircular
canals by an investigator standing behind the subject. The directions
of the head impulses were pseudorandomly intermingled and four to
six impulses were performed in each direction. For each semicircular
canal in the appropriate stimulus plane, the gain of the vestibulo-oc-
ular reflex (VOR) was determined by computing the coefficient ‘eye-
in-space displacement divided by head-in-space displacement’ with
head-in-space moved from 3° to 7° eccentricity from straight-ahead
[31]. Note that a decreased gain value in the direction of an individ-
ual semicircular canal does not necessarily imply that the pathology
is within this canal; the pathology could as well be somewhere along
the primary vestibular afferents from this semicircular canal.
■ Statistical analysis
To analyze the interference between the patterns of auditory and
vestibular damage, we used chi-square testing. Wilcoxon rank sum
test for equal medians was performed to determine the effect of age
on the high frequency vestibulo-ocular reflex as tested by head im-
pulses in healthy controls. The effects of age and gender on vestibular
and audiometric data at baseline data were analyzed with two-way
analysis of variance (ANOVA). Two-way ANOVA was also used to de-
termine whether semicircular canals for vestibular function or fre-
quencies for audiometric functions were differentially affected by FD.
If the outcome of the two-way ANOVA was statistically significant, we
performed multiple comparisons testing to discern the grouping
variables that differed significantly. To compare baseline data be-
tween different groups (e. g. males vs. females), we applied unpaired
t-tests. Effects of ERT at different time intervals were evaluated by
one-way ANOVA. If the outcome of ANOVA testing was statistically
significant, we performed multiple comparison testing to determine,
between which periods of ERT significant differences occurred.
Results
■ Vestibular and auditory function at baseline
Fig. 1 depicts measures of vestibular (head impulse test-
ing) and auditory (pure tone audiography) function in a
typical patient with Fabry disease (U. H.; age: 44 years).
For head impulses along the horizontal plane, gains of
the vestibulo-ocular reflex (VOR) were bilaterally re-
duced (Fig. 1A), reflecting hypofunction of the horizon-
tal semicircular canals (SCC) on both sides. Along the
RALP (= right anterior, left posterior) plane, VOR gains
were reduced for upward head impulses and normal for
downward head impulses (Fig. 1B), corresponding to re-
duced left posterior SCC and normal right anterior SCC
function. VOR gains along the LARP (= left anterior,
right posterior) plane were reduced in both directions
(Fig. 1C), i. e. both left anterior SCC and right posterior
SCC functions were reduced. In this patient, caloric irri-
gation revealed a normal vestibular function (canal
paresis factor: 16 %; data not shown). Pure-tone au-
diometry demonstrated bilateral high-frequency hear-
ing loss with a mean high-frequency loss (air conduc-
tion at 4 and 6 kHz) of 35 dB for the right and 67.5 dB for
the left ear (Fig. 1D). However, when these audiometric
data were corrected for age (ISO 7029, see Methods), the
high-frequency hearing loss was restricted to the left ear
(with 18.5 dB above the mean of the 90th percentiles for
4 and 6 kHz). Thus, in this Fabry patient, vestibular
deficits were found on both sides, while hearing func-
tion was impaired on one side only.
Fig. 2 shows the percentages of male (left bars) and
female (right bars) patients (N = 47; male = 25) with
vestibulo-auditory impairment at baseline examination
assessed by head impulse testing along different semi-
circular canal planes (HSCC: horizontal semicircular
canals; ASCC: anterior semicircular canals; PSCC: poste-
rior semicircular canals), caloric irrigation (CP: canal
paresis factor), and pure tone audiometry (Audio). Bars
indicating the percentage of bilateral (gray area) and
unilateral (white area) deficits are piled. For example,
the horizontal semicircular canals (Fig. 2, leftmost bar)
were affected bilaterally in 20 % and unilaterally in 48 %
of male patients. For caloric testing, only the percentage
of patients with a pathological canal paresis factor – a
measure of peripheral vestibular asymmetry (see Meth-
ods) – is depicted (white area), since no generally ac-
cepted parameter for bilateral impairment assessed by
caloric irrigation is available. Recall that caloric irriga-
tion was only performed in 24 patients (16 male), while
head impulses and pure tone audiometry were com-
pleted in all 47 patients.
Altogether, in 80 % of male and 77 % of female pa-
tients, head impulse tests in at least one of six semicir-
cular canal directions were abnormal. Pathological
asymmetries of caloric responses, i. e. with a canal pare-
sis factor > 25 %, were found in 21 % of male and in none
of female patients. Thus, vestibular deficits were more
frequently identified with search-coil head impulse test-
ing than with caloric irrigation. In pure tone audiome-
try, 88 % of male and 86 % of female patients showed im-
paired auditory function compared to age- and
gender-matched ISO control data. Hearing impairment
was sensorineural in all affected patients, i. e. no con-
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ductive or mixed hearing impairment was observed.
Configurations of audiometric thresholds were high-
frequency in 40 % of males and 9 % of females, flat in
52 % of males and 86 % of females, and sloping in 8 % of
males and 5 % of females (see Methods for definitions).
■ Relation between vestibular and auditory deficits at
baseline
We asked whether there was an association between
vestibular and hearing impairments in Fabry patients at
baseline. Table 1 compares vestibular (as assessed with
head-impulse testing) and auditory function in the
pooled population of male and female patients. Clearly,
vestibular function did not always parallel auditory
function, i. e. a vestibular deficit in a patient did not im-
ply a hearing impairment in the same patient, and vice
versa (chi square: p > 0.05). Likewise, no association be-
tween vestibular and auditory function was found when
analyzing data from males and females separately (data
not shown).
As demonstrated in Table 2, there was not even an as-
Fig. 1 Example of head impulses along
the horizontal (A), RALP (= right-ante-
rior & left-posterior semicircular canals)
(B) and LARP (= left-anterior & right-
posterior semicircular canals) (C) planes
as well as pure tone audiometry (D) in a
typical patient with Fabry disease (U. H.;
age 44 y) at baseline examination. A, B,
C If the vestibulo-ocular reflex (VOR)
were perfectly compensatory, traces
would be parallel to the abscissa (head-
in-space axis); if the VOR were absent,
traces would move on a 45° slope. Traces
are clipped beyond 10° eccentricity of
head-in-space. Dashed vertical lines in-
dicate intervals used to determine the
gains (see Methods). g: median gain
value during head impulses. D Pure tone
audiogram. Circles: hearing thresholds
of the right ear; crosses: hearing thresh-
olds of the left ear
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Fig. 2 Percentages of male (left columns; N = 25) and female (right columns;
N = 22) patients at baseline examination with unilateral (white area) and bilateral
(gray area) vestibular and auditory impairments. Horizontal (HSCC), anterior
(ASCC), and posterior (PSCC) semicircular canal function assessed with search-coil
head impulse testing. CP canal paresis factor, i. e. asymmetry of the vestibular func-
tion tested by caloric testing. Audio pure tone audiometry (hearing loss relative to
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sociation between vestibular and auditory function at
the level of ipsilateral labyrinths or their afferents.
Whether or not a Fabry patient had a vestibular deficit
on one side (as assessed with head-impulse testing) was
independent of the presence of an auditory deficit on the
same side, and vice versa (chi square: p > 0.05).Also sep-
arate analyses among male and female patients found no
association between vestibular and auditory function
on the same side (data not shown).
Fig. 3 compares patterns of ipsilateral vestibular and
auditory deficits of Fabry patients (results from right
and left sides are pooled). 32 % of patients showed typi-
cal patterns of vestibular and auditory deficits that are
expected if lesions were situated along the branches of
the vestibulo-cochlear nerve or labyrinthine artery [12,
33]. These patterns include 1) horizontal and anterior
SCC deficits, 2) posterior SCC and hearing deficits, and
3) deficits of all SCC and hearing. In the majority of pa-
tients (68 %), however, no pattern was identifiable.
■ Factors determining vestibular and auditory function
at baseline and its characteristics during ERT
To statistically analyze the influence of age and gender
on vestibular function, we first computed the average
VOR gain of head impulse testing along the three ipsi-
lateral semicircular canals of each ear in every patient.
This average VOR gain was then normalized by sub-
tracting the grand average of unilateral VOR gains in the
healthy control group. Since average unilateral VOR
gains in our group of healthy subjects did not signifi-
cantly decline with age (Wilcoxon rank sum test for
equal median p > 0.05), gain values of Fabry patients
were not age-corrected. Two-way analysis of variance
(ANOVA) demonstrated a significant (p < 0.01) influ-
ence of age and gender on vestibular function in the
Fabry patients. Fig. 4A illustrates that vestibular func-
tion in Fabry patients declines with age, i. e. the duration
of the disease, and is more reduced in male (squares)
than in female (circles) patients.
A similar analysis was performed to investigate the
influence of age and gender on auditory function. First,
differences of pure-tone air conduction thresholds rela-
tive to the 50 % percentile of age- and gender-matched
ISO 7029 control data were computed for the five tested
frequencies (0.5, 1, 2, 4, 6 kHz). These values were then
averaged separately for each ear to obtain a unilateral
measure of auditory function.As for vestibular function,
age and gender significantly (two-way ANOVA: p < 0.01)
influenced auditory function, with a decline of auditory
function with age (or duration of disease) and more re-
duced function in male patients, as shown in Fig. 4B.
While all semicircular canals in Fabry patients showed
similar (p > 0.05) impairment (Fig. 4C), auditory deficits
Table 1 Vestibular and auditory function of either ear in Fabry patients assessed
by search-coil head impulse testing and pure tone audiometry
Auditory function Vestibular function Total
(no. of patients) (no. of patients)
normal affected
normal 2 4 6
affected 8 33 41
total 10 37 47
Number of Fabry patients with normal or abnormal auditory or vestibular function.
Significance of chi square: p > 0.05
Table 2 Right- and left-ear vestibular and auditory function in Fabry patients as-
sessed by search-coil head impulse testing and pure tone audiometry
Auditory function Vestibular function Total
(no. of ears) (no. of ears)
normal affected
normal 9 12 21
affected 28 45 73
total 37 57 94
Number of ears in Fabry patients with normal or abnormal auditory or vestibular
function. Significance of chi square: p > 0.05
Fig. 3 Percentages for patterns of impaired semicircular canal (SCC) and auditory
function within the same ear, as expected by different topographical locations of
lesions due to impairments of labyrinthine nerve or blood supply or lesions within
the labyrinth. All: impairment of all three SCC and hearing within the same ear;
N = 11. HSCC + ASCC deficit of the horizontal and anterior SCC as expected from a
lesion along the superior branch of the vestibular nerve or labyrinthine artery;
N = 9. PSCC + Audio deficit of the posterior SCC and auditory function as expected
from a lesion along the inferior branch of the vestibular nerve or labyrinthine artery;
N = 10. No pattern no association of the three SCC and auditory function; N = 64
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were significantly (p < 0.01) different among tested fre-
quencies with largest differences at high frequencies
(Fig. 4D).
Fig. 5 illustrates the effect of ERT on overall vestibu-
lar and auditory function.As for Fig. 4, only results from
head impulse testing were considered for vestibular
function.Overall vestibular function of a patient was de-
fined as the average of VOR gains obtained by head im-
pulses along the six semicircular canal directions
(Fig. 5A). Likewise, the overall auditory function of a
subject was defined as the average of hearing thresholds
at 0.5, 1, 2, 4, and 6 kHz of both ears, whereby age- and
gender-correction of hearing thresholds were computed
by subtracting the age- and gender-matched 90th per-
centiles at each frequency before averaging (Fig. 5B).
Patients were divided into two groups depending on
whether the overall VOR gain (Fig. 5A) or the overall
hearing threshold (Fig. 5B), respectively, was within the
normal range (group_N, triangles) or reduced
(group_R, circles) relative to healthy subjects. At base-
line examination, i. e. prior to ERT administration, aver-
age overall VOR gains of group_R were not significantly
different between males and females although overall
VOR gains of females were less reduced than those of
males (average overall gains for male 0.59 ± 0.09, for fe-
male 0.61 ± 0.08; unpaired t-tests: p > 0.05; data not
shown). In contrast, for pure tone audiometry, the aver-
age overall hearing thresholds for group_R at baseline
were significantly different between male and female
patients with hearing thresholds in females less im-
paired than in males (average overall hearing thresholds
for male 47.3 dB ± 35.6, for female 21.7 dB ± 10.9; un-
paired t-tests: p < 0.05; data not shown). Overall VOR
gains and hearing thresholds at baseline in group_N
were not significantly different between male and fe-
male patients (unpaired t-tests: p > 0.05; data not
shown).
Because number of female patients receiving ERT
(N = 14) was small, data of male and female patients
were pooled for further analysis. Pooled data of
group_N (triangles) and group_R (circles) were then
partitioned into baseline examination (period I, i. e.
prior to ERT administration) and according to the time
passed from the beginning of the ERT to the date of ex-
Fig. 4 Differences of VOR gains ob-
tained by search-coil head impulse test-
ing along the three ipsilateral SCC of
each ear in every patient relative to
grand average of unilateral gains in
healthy controls (A, C) and differences of
pure-tone air conduction thresholds rel-
ative to ISO 7029 (B, D) in males
(squares) and females (circles) patients
at baseline examination. A Average VOR
gain deficits (error bars: ± 1SD) plotted
at different age intervals; C as A but plot-
ted for individual SCC. B Average pure-
tone air conduction thresholds relative
to 50th percentile of ISO 7029 (error bars:
± 1SD) plotted at different age intervals;
D as B but plotted for individual fre-
quencies. HSCC horizontal SCC; ASCC an-
terior SCC; PSCC posterior SCC. Note that
impairment of auditory function was
significantly greater at higher frequency
and at higher age, whereas vestibular
function was significantly more reduced
at higher age, but with no preference for
a specific SCC
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amination (period II: 1 day – 1.5 years; period III: 1.5
years – 3 years; period IV: 3 years – maximal 5 years;
dashed lines connect average of corresponding groups;
dashed horizontal line: lower limit of data from healthy
subjects).For group_N,no significant change in both av-
erage overall VOR gain (Fig. 5A) and average overall
hearing threshold (Fig. 5B) was noted during 60 months
(ANOVA: p > 0.05). In contrast, average overall VOR gain
differed significantly among the periods in group_R
(ANOVA: p < 0.01). Specifically, multiple comparison re-
vealed a significant (p < 0.05) vestibular improvement
during the first 1.5 years of ERT (Fig. 5A). Thereafter,
overall average VOR gain did not significantly change.
For auditory function, no significant changes of aver-
age hearing thresholds in group_R were observed dur-
ing 60 months,although a slight tendency for further de-
terioration was visible (Fig. 5B).The same analysis as for
overall hearing thresholds (see Fig. 5B) was repeated for
single frequencies (0.5, 1, 2, 4, 6 kHz), average high fre-
quency (4 and 6 kHz), and average low frequency (0.5
and 1 kHz). In these frequency-specific analyses, we also
did not observe any significant changes in both
group_N and group_R during ERT (data not shown). Fi-
nally, since in baseline examination, hearing thresholds
of female patients differed significantly from male pa-
tients, all above analyses were repeated for male patients
only. Again, no significant changes of auditory function
in group_ N and group_R were observed during ERT
(data not shown).
In summary,ERT in Fabry patients led to a significant
improvement of vestibular function, which took place
within the first year of treatment, while auditory func-
tion did not significantly change within the first five
years of ERT.
Discussion
Our study confirms the high prevalence of both pro-
gressive hearing and vestibular loss in patients with
Fabry disease and presents detailed analysis on the as-
sociation between auditory and vestibular deficits be-
fore and during treatment with enzyme replacement
therapy (ERT). Sensorineural hearing loss was observed
in 88 % of males and 86 % of females and comprised all
frequency ranges. Hearing loss was significantly influ-
enced by age and gender.In particular,age-corrected au-
ditory function was more impaired at higher age and
deficits were greater in male than in female patients. In
addition,auditory function differed significantly among
tested frequencies with largest deficits at high frequen-
cies. Vestibular deficits were present in 80 % of males
and 77 % of females. As in auditory function, vestibular
function was significantly more impaired in males and
at higher age.
The high prevalence of vestibular deficits in our
Fabry patients clearly differs from reports of previous
studies [9, 29]. We believe that our finding is most likely
due to the higher sensitivity of the search-coil head im-
pulse test in detecting vestibular hypofunction com-
pared to caloric irrigation [37]. In fact, only about 21 %
of our patients showed vestibular abnormalities when
assessed by caloric irrigation. This relatively low per-
centage of caloric abnormality agrees with results from
the previous studies [9,29].Two factors may explain why
patients with Fabry disease show vestibular hypofunc-
tion more frequently when evaluated with search-coil
head impulse testing compared to caloric irrigation: 1)
The canal paresis factor, which is used to quantify
caloric irrigation becomes pathological only if vestibu-
lar damage is asymmetric; in other words, the canal
paresis factor is insensitive to roughly bilateral vestibu-
lar hypofunction. Head impulses, however, show that bi-
lateral vestibular damage is not uncommon in Fabry pa-
tients (see Fig. 2). 2) Typically, the recovery of the
vestibulo-ocular reflex (VOR) is frequency-dependent
and incomplete at higher frequencies and accelerations
[28, 30, 31]. While in patients after vestibular neuritis or
vestibular neurectomy the low and medium frequency
VOR, as assessed by turntable testing or caloric irriga-
tion, is centrally compensated within several weeks, the
high-frequency VOR, as assessed by head impulse test-
ing, remains deficient even after many years [1–3, 8, 17,
20, 23, 37, 38]. As an additional factor we cannot exclude
the possibility that high vestibular frequencies are more
vulnerable to the pathological processes of Fabry dis-
Fig. 5 Average of overall VOR gains (error bars: ± 1SD) for search-coil head im-
pulses (A) and overall hearing thresholds (error bars: ± 1SD) for pure tone audiom-
etry (B) at baseline and during enzyme replacement therapy (I: baseline examina-
tion, i. e. prior to ERT; II: 1 day – 1.5 year; III: 1.5 year – 3 years; IV: 3 years – maximal
5 years). Data from males and females are pooled. Triangles: patients with normal
values (group_N). Circles: patients with reduced values (group_R). Asterisks: sig-
nificant (p < 0.05) differences of average VOR gains in group_R between periods I
and II, I and III as well as I and IV. Note that here only patients receiving ERT were
included in baseline examination (N = 38; males: N = 24)
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ease than low vestibular frequencies.The fact that, in our
study, all Fabry patients with pathological caloric irriga-
tion had reduced head impulses as well and were more
than 50 years old might support this hypothesis.
The location of vestibulo-cochlear damage in Fabry
disease is not known. Possible sites are the vestibulo-
cochlear labyrinth, the eighth cranial nerve or the root
entry zone of the eighth cranial nerve.We speculate that
the impairment is most likely located within the
vestibulo-cochlear labyrinth,since the majority of Fabry
patients showed no specific lesion pattern, as one would
expect if lesions were proximal of the labyrinth along
the superior (i. e. concomitant anterior SCC and lateral
SCC deficits) or the inferior (i. e. concomitant posterior
SCC and auditory deficit) branch of the vestibular nerve
or labyrinthine artery [12].We emphasize, however, that
with our functional methods, we are not able to deter-
mine whether neural (including hair cells) or vascular
structures within the labyrinth are affected in Fabry dis-
ease. Histological findings by Schachern et al. in tempo-
ral bones of two patients with Fabry disease suggest, on
the basis of glycosphingolipid accumulation in the stria
vascularis and in the spiral ganglion cells, that the etiol-
ogy of cochlear lesions at the level of the hair cells is pri-
marily of vascular origin [35]. A recent audiometric
study by Ries et al. also comes to the conclusion that the
auditory deficit is due to a cochlear impairment [34].
The effect of enzyme replacement therapy (ERT) was
analyzed for vestibular and auditory function at follow-
up examinations over five years. Previous studies in pa-
tients after vestibular neuritis and neurectomy have
shown that unilateral vestibular deficits also influence
the vestibulo-ocular reflex towards the contralateral
healthy side by central mechanisms [23, 31]. Therefore,
to investigate vestibular function during ERT, we aver-
aged the vestibulo-ocular responses along the six semi-
circular canals for each patient. For comparison, the
same binaural averaging was done for auditory func-
tion. During ERT over 60 months, auditory function did
not significantly change in our patients, i. e. there was no
indication for recovery, but also no indication for dete-
rioration.So far, three other studies have reported on au-
ditory function under ERT.While Conti et al. did not see
an improvement during the first 12 months [9], Hajioff
et al. found a significant decrease of sensorineural hear-
ing loss in the high frequency range after 18 months
[15]. Hajioff et al. three years later found in the Fabry
Outcome Survey a significant decrease of sensorineural
hearing loss over all frequencies after 12 months [16]. A
comparison between our and the other studies should
only be done with caution because of different analyti-
cal methods. Conti et al. and the Fabry Outcome Survey
study excluded extreme audiometric frequencies when
calculating the amount of hearing impairment, while
Hajioff et al. focused on the high frequency hearing im-
pairment and averaged the hearing thresholds at 4 and
8 kHz. Our study provides evidence that the overall au-
ditory function (average over all hearing thresholds in
both ears) as well as the high-frequency auditory func-
tion (average of hearing thresholds at 4 and 6 kHz in
both ears) remains stable during ERT. Thus, to date
whether or not auditory function improves under ERT is
still not conclusively answered.
In contrast to auditory function, the vestibular func-
tion in its high-frequency range (assessed by head im-
pulse testing) significantly improved during the first one
and a half years of ERT and remained unchanged there-
after. In a preliminary study, we reported on the effect of
ERT on vestibular function as tested by head impulses in
a much smaller population of Fabry patients. There we
found a tendency of vestibular recovery within the first
12 months; these results, however, were not statistically
significant [32]. With about twice the number of Fabry
patients in the present study the vestibular improve-
ment turned out to be significant.
In conclusion, we have demonstrated that in patients
with Fabry disease vestibular deficits occur as fre-
quently as auditory deficits. Functional tests support the
hypothesis that the vestibular and auditory systems are
mainly affected within the labyrinth, probably at the
level of the hair cells. For the detection of vestibular
deficits the search-coil head impulse test is more sensi-
tive than caloric irrigation.Finally,ERT significantly im-
proves the vestibular function in its high-frequency
range, while the auditory function is at least stabilized.
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